New Blood Thinner for Stroke Prevention - Atrial Fibrillati...

Atrial Fibrillation Support

32,280 members38,541 posts

New Blood Thinner for Stroke Prevention

AustinElliot profile image
16 Replies

Hi all,

Some exciting news for those on Blood Thinners for AF.

Abelacimab is a monoclonal antibody given just once a month by subcutaneous injection. It is not cleared by the kidneys, doesn’t require dose adjustments, and is not affected by other drugs. It achieves near-complete 99% inhibition of Factor XI over the entire month.

In afib patients, the 150 mg dose showed a 67% reduction in relevant bleeding compared to rivaroxaban, a highly significant 74% reduction in major bleeding, and a 93% reduction in gastrointestinal (GI) bleeding.

Because of these fantastic results, the Data Monitoring Committee (DMC) stopped the study early (back in September) due to such a substantial bleeding reduction. Since many people cannot take conventional anticoagulants, the hope is that abelacimab (and other Factor XI inhibitors) will address this pressing need for reducing stroke risk without causing bleeding.

The Food and Drug Administration (FDA) has granted abelacimab Fast Track Status for stroke prevention in those with afib due to this important unmet medical need.

stopafib.org/afib-news-even...

Written by
AustinElliot profile image
AustinElliot
To view profiles and participate in discussions please or .
Read more about...
16 Replies
mjames1 profile image
mjames1

"Some exciting news for those on Blood Thinners for AF."

----

First of all, thank you for posting. Yes, exciting. And it's not only exciting news for those on blood thinners, but also exciting news for those who have chosen not to take blood thinners because of quality of life issues".

From the article...

"In our recent large patient survey, a considerable number of afib patients reported that bleeding and/or bruising problems since starting an anticoagulant had a significant impact on their quality of life. If approved, this could offer patients the protection they seek from strokes with minimal to no risk of bleeding.”

Let's just hope that the results hold up with the, now recruiting, phase 3 trial (Lilac-Timi 76 Study) where the other component -- stroke reduction -- will be more fully addressed.

Jim

bean_counter27 profile image
bean_counter27 in reply tomjames1

Also exciting for those of us whose CHADVASC score that doesn't currently indicate use of blood thinners/anticoagulants. It's not that we (people with low CHADVASC scores) don't need protection from having strokes but the benefits are currently outweighed by the risks of major bleeding from the current range of blood thinners/anticoagulants. If the risks of using this new anticoagulant are significantly reduced and it provides the same/similar benefits then it should expand the scope for using it for younger AF sufferers.

ozziebob profile image
ozziebob in reply tobean_counter27

Trying not to be negative about this promising news, and with the hope that stroke risks are also lowered, but I sense the cost of this type of mAb drug might still mean it is restricted to small cohorts of patients? Just wondering.

frazeej profile image
frazeej in reply toozziebob

Ozziebob: Agree with you. Biologics don't come cheap!

Another issue is the one month dosing schedule. Sounds ideal, except for an untoward reaction, which could then last for a month! Sometimes shorter half lives are beneficial!

JimF

mjames1 profile image
mjames1 in reply toozziebob

OB: " I sense the cost of this type of mAb drug might still mean it is restricted to small cohorts of patients?"

-----------

Yes, for now while it's still in the trial phase, but hopefully it will be available to the public at large at a later time should the next stage of these trials be successful.

JIm

Aus19 profile image
Aus19

Thank you from Australia for this very interesting post.

Interesting news, it’s not something we are familiar with here in the UK but no doubt that will change in time.

Afibtastic profile image
Afibtastic

That is good news. Any Idea of time of release to public?

I like to surf, ski and mountain bike but I am constantly worried about a head bump/impact.

It will probably become available when I am too old to do those activities.

AustinElliot profile image
AustinElliot in reply toAfibtastic

I am sorry I don't, just came across the article - its on fast track for FDA approval, so I imagine fairly soon. I am pretty sure there are other drugs researching targeting the Factor XI inhibitors

mjames1 profile image
mjames1 in reply toAustinElliot

Still needs to go through a Phase III trial. The current trial shows that it reduces bleeds, but they need another trial to show that it prevents strokes on par with DOAC's.

Jim

mjames1 profile image
mjames1 in reply toAfibtastic

Still needs a phase III trial to demonstrate that it prevents strokes on par with DOAC's, which is just starting to enroll, so it may be some time. 1-3 years?????

Jim

Finvola profile image
Finvola

Excellent news for so many people . . . thank you for posting.

mary70 profile image
mary70

Excellent news...

Silky57 profile image
Silky57

Wow that if excellent news & one to keep an eye on. Thank you for sharing.

HGates profile image
HGates

Don’t want to be a party pooper but I think another factor XI inhibitor (Asundexian) just failed dismally in the phase III Oceanic stroke trial which got stopped early due to lack of efficacy in preventing stroke. Reduced bleeding is great but not if the drug fails in its principal task.

Alphakiwi profile image
Alphakiwi

What to do meantime. Cant wait.

Not what you're looking for?

You may also like...

Which "Blood thinner"

I Have Atrial Fibrillation: Which New Blood Thinner Should I Take? By T. Jared Bunch, MD Published...

Stroke Prevention Day

The Stroke Association are highlighting the link between AF and the possibility of a stroke. I can...
john-boy-92 profile image

Your views on stroke prevention treatment in AF

Morning all We have been approached by a research company who are looking into patient perceptions...

Stroke risk

A question to throw out there - if being over 65 and female gives you a Chads of 2 and deems you...
Spangle14 profile image

New Anticoagulant looks promising

There's a new anticoagulant that's in trials on people with AF. It appears to cause minimal...
MarkS profile image

Moderation team

See all
Emily-Admin profile image
Emily-AdminAdministrator
Kelley-Admin profile image
Kelley-AdminAdministrator
jess-admin profile image
jess-adminAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.